[Clinical experience with a new combination drug (metrotonin) in the treatment of depressions and autonomic dystonia].
D001341:Autonomic Nervous System; D001342:Autonomic Nervous System Diseases; D001463:Barbiturates / Q000627:therapeutic use*; D003863:Depression / Q000628:therapy*; D003866:Depressive Disorder; D004421:Dystonia; D006801:Humans; D008694:Methamphetamine / Q000031:analogs & derivatives; D010627:Phenethylamines / Q000627:therapeutic use*
D001463:Barbiturates; D010627:Phenethylamines; D008694:Methamphetamine; C003714:dimethylamphetamine
AUTONOMIC NERVOUS SYSTEM/diseases; BARBITURATES/therapeutic use; DEPRESSION/therapy; PHENYLETHYLAMINES/therapeutic use
Klinische Erfahrungen mit einem neuen Kombinationspräparat (Metrotonin) zur Behandlung von Verstimmungszuständen und vegetativen Dysregulationen.